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Abstract
VIRAL OVEREXPRESSION OF RPRD2 IN MOUSE NUCLEUS ACCUMBENS INDUCES ANXIETY-LIKE
BEHAVIOR AND REGULATES GENES ASSOCIATED WITH MICROTUBULE TRANSPORT
Claire N. Atiyeh
A thesis in partial fulfillment of the requirements for the degree of Master of Science in
Anatomy and Neurobiology at Virginia Commonwealth University.
Virginia Commonwealth University, 2022
Peter J. Hamilton, Ph.D., Assistant Professor, Department of Anatomy and Neurobiology

Anxiety disorders are the most prevalent mental illness in the United States with many
individuals underdiagnosed and undertreated (Anxiety & Depression Association of America,
2021; Bandelow et al., 2017). While stress is a known risk factor for developing anxiety
disorders, there is emerging evidence that biological variability in the expression of key proteins
in the brain may contribute to regulating an organism’s stress-related behaviors. Earlier work
from our laboratory identified a protein, called Regulation of Nuclear Pre-mRNA Domain
Containing 2 (RPRD2), that was differentially expressed in the brain of mice stratified in terms
of their phenotypic response to chronic stress (Hamilton et al., 2020). RPRD2 protein was
elevated in the nucleus accumbens (NAc) of stress resilient animals–mice that display fewer
behavioral abnormalities and more successful adaptation to stressors–and is predicted to play a
significant role in gene transcription (Hamilton et al., 2020; Sjöstedt et al., 2020). In a cohort of
mice exposed to chronic social defeat stress (CSDS), this protein was revealed as differentially
expressed in the ventral hippocampus, medial prefrontal cortex, and NAc, of which RPRD2 was
the top most affected protein in the NAc (Hamilton et al., 2020). More specifically, previously
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published reports suggest that RPRD2 functions to modulate RNA polymerase II activity by
dephosphorylating serines at position 5 of the carboxyl-terminal domain of RNA polymerase II
(Sjöstedt et al., 2020). Due to the correlation between RPRD2 and stress-induced behavioral
adaptations in laboratory rodents, I aim to build upon this data and decipher this protein’s
influence on stress-related behavior, mechanism of action in the NAc, and any potential impact
it may have on medium spiny neuron (MSN) morphology, the major neuron functional unit in
the NAc.
In order to expand upon the work conducted by Hamilton et al., I first exposed mice to a
period of CSDS and conducted behavioral tests to determine the extent to which elevated levels
of RPRD2 in the NAc impacted behavior. Following a period of CSDS, male mice with viral
overexpression of RPRD2 spent less time in the open arms of an Elevated Plus Maze (EPM) test,
a paradigm that quantifies anxiety-like behavior; however, no difference was observed with a
Social Interaction test or thigmotaxis analysis–the tendency of mice to remain close to the walls
(Bailey & Crawley, 2009; Kraeuter et al., 2019; Rodgers & Dalvi, 1987). These findings support
the conclusion that viral overexpression of RPRD2 specifically impacts anxiety-like behavior,
rather than social behavior–another behavioral domain known to be sensitive to chronic stress.
I then began to inquire about not only RPRD2’s behavioral impact, but also RPRD2’s
molecular impact in the NAc. It was previously reported that RPRD proteins recruit deacetylases
of lysine residues at position 7–specifically, HDAC1–which in turn allows RPRD to decrease
phosphorylation of serines at position 5 of the carboxyl-terminus domain of RNA Polymerase II
(Ali et al., 2019). Because RNA polymerase II facilitates transcription, I examined RPRD2’s
impact on its Phospho Serine 5 levels via Western blots in order to explore its particular role in
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transcription. Although no significant correlation was found, tissue samples from mice virally
overexpressed with RPRD2 revealed a downward trend in RNA Polymerase II Phospho Serine 5
levels (normalized to β-actin). This led me to further inquire about the exact downstream
mechanistic impact of this protein and its regulation of transcription within the NAc.
We performed RNA sequencing to determine the gene loci regulated by viral overexpression of RPRD2 in the NAc. RPRD2 overexpression was correlated with upregulated genes
canonically enriched in fibroblast cell-types and associated with downregulated genes enriched
in ependymal cell-types. Following a gene ontology analysis performed on the significantly
regulated differentially expressed genes (DEGs) in the RNA sequencing data, microtubule-based
movement was the biological process most significantly associated with RPRD2 downregulated
transcripts. Due to this finding, more research is needed regarding the impact of viral
overexpression of RPRD2 on downregulating microtubule transport within RPRD2 expressing
cells in the NAc.
Furthermore, previous studies have shown decreased strength of NAc synapses of mice
expressing depression-like behavior following CSDS (Bagot et al., 2015; LeGates et al., 2018).
Thus, enhancing activity in MSNs may result in resilient behavior; contrastingly, diminishing
MSNs may result in anxiety-like behavior following CSDS (Francis & Lobo, 2017). To test this, I
observed the contribution of viral overexpression of RPRD2 on medium spiny neuron
morphology. Based on observation, there appeared to be less dendritic branching in neurons
virally overexpressed with RPRD2; however, a Sholl analysis must be conducted in the future in
order to solidify this observation.
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Overall, I hypothesize that viral overexpression of RPRD2 in the NAc regulates anxietylike behavior by decreasing RNA polymerase II-mediated transcriptional activity, which
consequently impacts medium spiny neuron morphology in the NAc. In synthesizing my
research, I will describe my comprehensive knowledge of RPRD2 and its relationship to chronic
stress and anxiety, as well as a description of the materials and methods used to demonstrate
the effects of RPRD2 in the NAc. I will then describe the results collected and discuss its
potential ramifications in understanding the molecular drivers of neuropsychiatric syndromes.
The results of this study can help to better understand how RPRD2 serves as a link between
chronic stress and behavioral responses, and the mechanistic role of RPRD2 in the NAc. In the
future, I hope this data can facilitate studies dedicated to targeting RPRD2 in order to develop
effective pharmacotherapies for those with anxiety disorders.
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Introduction

Anxiety disorders are the most prevalent mental illness in the United States, affecting
18.1% of the population–ages 18 or older–each year (Anxiety & Depression Association of
America, 2021). Despite their prevalence, anxiety disorders often go underrecognized and
undertreated, with only 36.9% of those suffering receiving treatment (Anxiety & Depression
Association of America, 2021; Bandelow et al., 2017). Below, I review data related to the
contributions of RPRD2 on anxiety-like behavior. Regulation of nuclear pre-mRNA domain
containing 2 (RPRD2) is an understudied protein that is implicated in regulating RNA
polymerase II binding activity and mRNA 3’ end processing (Alliance of Genome Resources,
2021). Emerging evidence suggests that resilient mice–or mice that display fewer stressinduced behavioral abnormalities and more successful behavioral adaptation to stressors–have
higher levels of RPRD2 protein within the NAc in comparison to susceptible mice–or mice that
develop stress-induced behavioral deficits– when exposed to chronic social defeat stress
(Hamilton et al., 2020; Wendelmuth et al., 2020). To explore this further, I hypothesized that
mice with viral overexpression of RPRD2 in the NAc would display fewer anxiety-like behaviors
when exposed to chronic stress than mice without.
Evidence also suggests that RPRD proteins decrease phosphorylation of serines at
position 5 on the carboxyl-terminus domain of RNA polymerase II (Ali et al., 2019). Thus, I
hypothesized that mice with viral overexpression of RPRD2 would show less phosphorylation of
serines at position 5 and therefore lower levels of transcription due to reduced RNA
polymerase II activity. Additionally, previous studies have shown decreased strength of NAc
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synapses of mice expressing depression-like behavior following CSDS (Bagot et al., 2015;
LeGates et al., 2018). Due to this evidence, enhancing activity in MSNs may result in resilient
behavior while diminishing MSNs may result in depression-like behavior following CSDS (Francis
& Lobo, 2017). Should these mice not show resilience, I hypothesized that there would be a
decrease in MSN dendrites following viral overexpression of RPRD2. Collectively, an
understanding of RPRD2 and its impact on brain and behavior will build a stronger framework
behind the mechanism of anxiety disorders. In addition, these data will raise awareness
regarding the implications of chronic stress within the NAc.

CoronaVirus Disease 2019

Fear of the unknown leads to higher anxiety levels in both those with and without preexisting mental health conditions (Torales et al., 2020). Currently, very little is known about the
CoronaVirus Disease 2019 (COVID-19); therefore, it poses a global risk to mental health (Talevi
et al., 2020). COVID-19 is a pandemic caused by the novel Coronavirus strain SARS-CoV-2 (Talevi
et al., 2020). Quarantine, isolation, and social distancing has been enacted in order to restrict
COVID-19 transmission. The World Health Organization warns that these restrictions and
disruptions in people’s routines may lead to loneliness, anxiety, depression, insomnia, harmful
alcohol/drug use, and suicidal behavior (Selçuk et al., 2021). This statement is further solidified
by a study conducted in the United Kingdom in which, of the 44% suffering cluster of people,
93% report feeling more anxious and depressed since lockdown measures were introduced
(Duffy et al., 2020).
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Psychological reactions to pandemics include maladaptive behaviors, emotional distress,
and defensive responses such as: anxiety, fear, frustration, loneliness, anger, boredom,
depression, stress, and avoidance behaviors (Talevi et al., 2020). In particular, headline stress
disorder can be observed in which further progression to physical and mental disorders may be
observed due to a high emotional response–such as stress and anxiety–to reports from the
news media (Talevi et al., 2020). COVID-19 related chronic stress has profound impacts on longterm mental health (Qi et al., 2021). Findings from China suggest that more than 25% of the
general population experienced moderate to severe levels of stress and/or anxiety-related
symptoms in response to COVID-19 (Nikčević & Spada, 2020). Even one year after the first
COVID-19 outbreak, the prevalence of anxiety in the general population has not changed (Qi et
al., 2021). This indicates that the impact of the pandemic on mental health has not been
attenuated despite control of its spread. COVID-19 impact on mental health may be longlasting. Hopefully, the data presented below may aid in understanding the mechanism behind
and in developing effective pharmacotherapies for the large portion of the population suffering
from anxiety disorder.

Chronic Stress and Anxiety

Stress can be both objective and subjective with respect to physical and psychological
stressors (Mariotti, 2015). Unpleasant, aversive, or threatening situations initiate a stress
response in the body in order to allow it to properly cope with the stress (Lucassen et al., 2014).
In humans, unpleasant surprises, injuries, financial difficulties, loss, physical threats, etc. are all
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examples of different types of stressors. Stress becomes chronic during instances in which the
stressor becomes overwhelming and unresolvable over a period of time (Mariotti, 2015).
Physiologically, glucocorticoid receptors in the brain that normally provide a negative feedback
mechanism to regulate the stress response become resistant, and systemic levels of stressrelated molecular mediators remain high (Mariotti, 2015). This in turn damages multiple organs
and tissues long term (Mariotti, 2015). Diseases linked to stress include cardiovascular
dysfunctions, diabetes, cancer, autoimmune syndromes, and mental illnesses such as
depression and anxiety disorders (Lucassen et al., 2014; Mariotti, 2015).
Stress is the most common risk factor for the development of depression and anxiety
disorders (Lucassen et al., 2014; Pêgo et al., 2010). About one-half of those with depression
disorder are also diagnosed with an anxiety disorder, and the two are often considered
comorbid disorders (Anxiety & Depression Association of America, 2021). These two comorbid
disorders suggest the existence of an anxiety–depression spectrum according to measures of
distress and fear (Hoffman, 2015). Two examples on the “distressed end” of this spectrum are
generalized anxiety disorder and major depressive disorder. Generalized anxiety disorder is the
most common anxiety disorder affecting 3.1% of the United States population, while major
depressive disorder affects 6.7% of the United States population (Anxiety & Depression
Association of America, 2021). Examples on the “fear end” of this spectrum are panic disorder,
affecting 2.7% of U.S. adults, and specific phobias, affecting 8.7% of U.S. adults. Social anxiety
disorder is another example of an anxiety disorder, and obsessive-compulsive disorder and
post-traumatic stress disorder are closely related. Treatment for these disorders include:
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psychotherapy, pharmacotherapy, exercise, support groups, stress management techniques,
hypnosis, and complementary medicine methods (Bandelow et al., 2017).

Nucleus Accumbens

The nucleus accumbens (NAc) is connected to the limbic system of the brain and is the
most inferior part of the striatum, which comprises the caudate nucleus and the putamen
(Mavridis, 2015). As part of the reward circuitry in the brain, the NAc plays a key role in food
intake, sexual behavior, reward-motivated behavior, stress-related behavior and substancedependence stress-related behavior (Mavridis, 2015; Sjöstedt et al., 2020). Evidence has shown
that deep brain stimulation of the NAc is correlated with antidepressant and anxiolytic effects
(Mavridis, 2015). As such, changes in the NAc affect psychiatric disorders such as depression,
schizophrenia, substance abuse disorder, obsessive-compulsive disorder, and anxiety disorders.
The nucleus accumbens receives dopaminergic inputs from the ventral tegmental area
(Baik, 2020). Dopamine is produced in the substantia nigra and ventral tegmental area of the
midbrain and is involved with reward, mood, pleasure, smooth motor movements, focus, and
attention. Shortages in dopamine lead to aggression, compulsive behavior, overeating, and
depression. (Sheffler, 2021). The NAc also receives glutamatergic inputs from the hippocampus,
prefrontal cortex, basolateral amygdala, and thalamus (Baik, 2020; Bagot et al., 2015).
Glutamate is the primary excitatory neurotransmitter in the brain and glutamate deficiency
leads to fatigue, lack of focus, apathy (Bagot et al., 2015). Medium spiny neurons (MSNs) are
the primary neurons that integrate these cortico-limbic afferens with the NAc as the afferents
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terminate on the MSN dendritic spines, which are capable of storing information and
transmitting electrical signals (Dobrof & Penrod-Martin, 2012; Lucassen et al., 2014).
MSNs from the NAc also project GABA/gamma aminobutyric acid outputs to the ventral
pallidum, the medial area of the globus pallidus, the substantia nigra, and the lateral
hypothalamus (Baik, 2020; Dobrof & Penrod-Martin, 2012). GABA is the primary inhibitory
neurotransmitter in the brain and shortages lead to stress and anxiety, depression, ADHD, panic
disorders, and many others (Sheffler, 2021). For example, animals displaying anhedonia and
depression-like behavior reveal an enlargement of MSNs in the NAc (Bessa et al., 2013).

NAc and Stress

Stress affects the dopamine levels in the brain (Baik, 2020). Long-term, chronic stress
weakens reward sensitivity by dampening the ability to cope with stressors and recruit
appropriate reward-related neural connections (Baik, 2020). Stressful events negatively
regulate dopaminergic neuronal activity which can lead to chronic stress-induced depression
(Baik, 2020). Stress can also cause reduction in volume of structures within the brain and
changes in neuronal plasticity due to decreased spine density (Lucassen et al., 2014).
Chronic social defeat stress (CSDS) is a widely utilized laboratory technique to induce
depression-like and anxiety-like behaviors in rodents, as is demonstrated by anhedonia and
social avoidance (Golden et al., 2011). Glutamatergic afferents to the NAc regulate
susceptibility and resiliency to CSDS in rodents (Bagot et al., 2015). Previous studies have shown
a decrease in both the glutamatergic transmission of prefrontal cortex-NAc synapses and the
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strength of hippocampus-NAc synapses of mice expressing depression-like behavior following
CSDS (Bagot et al., 2015; LeGates et al., 2018). Thus, diminishing MSN function may result in
susceptible, depression-like behavior following CSDS (Francis & Lobo, 2017).
Rodent models are leading neuropsychiatric research as they can aid in the assessment
of endophenotypes for anxiety disorders (Bailey & Crawley, 2009; Hoffman, 2015).
Manipulation of the protein expression in the brain, application of stressors, and quantification
of different behavioral paradigms were all used in order to model stress and assess anxiety-like
behavior.

Regulation of Nuclear Pre-mRNA Domain Containing 2

Emerging evidence suggests that resilient mice have higher levels of RPRD2 within the
NAc in comparison to susceptible mice when exposed to chronic social defeat stress (Hamilton
et al., 2020; Wendelmuth et al., 2020). In fact, RPRD2 was the only protein affected across the
three brain areas investigated in this study: the ventral hippocampus, the medial prefrontal
cortex, and the NAc (Hamilton et al., 2020). It was also the top most affected protein in the NAc
of a cohort of mice exposed to CSDS (Hamilton et al., 2020). Given the bi-directional regulation
of RPRD2 in resilient versus susceptible animals in multiple limbic brain regions and its
magnitude of effect in the NAc, we felt this data warranted additional inquiry about the role of
this understudied protein on stress-exposed mice.
RPRD2–also referred to as REAF (RNA-associated early-stage antiviral factor) in certain
literature–is elevated in the NAc of resilient animals and is predicted to play a significant role in
gene transcription (Hamilton et al., 2020; Sjöstedt et al., 2020). RPRD2 is a protein that binds to
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the carboxyl-terminal domain (CTD) of RNA polymerase II and restricts its function (Sjöstedt et
al., 2020). It is predicted to be involved in mRNA 3’-end processing (Alliance of Genome
Resources, 2021). Thus, higher levels of RPRD2 may lead to less mRNA transcribed from DNA;
yet, the gene loci most sensitive to this regulation remain unknown.
Other regulation of nuclear pre-mRNA domain homologs also exist: RPRD1A and
RPRD1B. The two share similar amino acid sequences and domains (Ni et al., 2011). All three
RPRD proteins contain CTD-interaction domains, and are expressed in the majority of human
cell types and tissues. RPRD2 is much larger, with a length of around 1460 amino acids, a mass
of 150,000 Daltons, and serine and proline rich regions (Ni et al., 2011; Sjöstedt et al., 2020).

RPRD2 and RNA Polymerase II

The CTD of RNA polymerase II contains repeats of the sequence Y1-S2-P3-T4-S5-P6-S7
(Ni et al., 2014). The total amount of CTD repeats varies in different organisms; however, homo
sapiens and mus musculus both contain 52 heptad repeats on the CTD (Srivastava & Ahn,
2015). 21 of the heptad repeats are in consensus, while 31 diverge from the consensus (Ali et
al., 2019). This divergence occurs most commonly at position 7, in which S7 can be replaced
with N7 (arginine), T7 (threonine), or K7 (lysine) (Ali et al., 2019; Srivastava & Ahn, 2015). Lysine
residues at position 7 are needed for transcription elongation (Ali et al., 2019). Acetylation of
lysine residues at position 7 occurs at around 80% of actively transcribed genes, which indicates
its role in regulating the transition from transcription initiation to elongation.
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During early transcription, a mediator complex is recruited to the gene promoter of
unphosphorylated RNA polymerase II (Srivastava & Ahn, 2015). This mediator complex then
stimulates cyclin-dependent kinase 7–a subunit of the general transcription factor TFIIH–in
mammals to phosphorylate S5 and S7 on the CTD of RNA polymerase II. Specifically, S5p aids in
the transition from transcription initiation to elongation by inducing the dissociation of the
mediator from the pre-initiation complex, stimulating RNA polymerase II for promoter
clearance, and recruiting pre-mRNA capping enzymes (Ali et al., 2019; Srivastava & Ahn, 2015).
Thus, dephosphorylation of S5p may cause a stall in the transition from transcription initiation
to elongation.
Different mechanisms can be used to create a CTD code that acts as a scaffold and
recruits regulators of transcription which post-translationally modify RNA polymerase II (Ali et
al., 2019; Ni et al., 2014). Specifically, RPRD proteins have been found to control the CTD
phosphorylation activity by reducing CTD S5- and S7-phosphorylated RNA polymerase II (Ni et
al., 2011).
Evidence has shown that acetylation of lysine residues at position 7 regulates the
phosphorylation of serines at position 5 (S5p) (Ali et al., 2019). First, acetylation of lysine
residues at position 7 enhances binding to the CTD-interacting domain of RPRD proteins and
recruits RPRD proteins to the initiated RNA polymerase II complex. S2p also enhances the
interaction between the RNA polymerase II CTD and RPRD CTD-interaction domains (Ni et al.,
2014). Then, RPRD proteins recruit deacetylases of lysine residues at position 7–specifically,
HDAC1–which in turn allows RPRD to decrease phosphorylation of S5p (Ali et al., 2019).
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Researchers posit that RPRD proteins facilitate S5p dephosphorylation by RNA polymerase II
associated protein 2, their interacting S5 phosphatase (Ali et al., 2019; Srivastava & Ahn, 2015).
As mentioned, evidence suggests that resilient mice have higher levels of RPRD2 within
the NAc in comparison to susceptible mice when exposed to chronic social defeat stress
(Hamilton et al., 2020; Wendelmuth et al., 2020). As stress is the most common risk factor for
the development of depression and anxiety disorders, and the two are often considered
comorbid disorders, viral overexpression of RPRD2 in the NAc may regulate anxiety-like
behaviors (Anxiety & Depression Association of America, 2021; Lucassen et al., 2014; Pêgo et
al., 2010). This regulation may occur mechanistically through RPRD2’s potential impact on gene
transcription as evidenced by RPRD proteins and their dephosphorylation of S5p on the CTD of
RNA polymerase II (Ali et al., 2019; Ni et al., 2014). Additionally, previous studies have shown a
decrease in both the glutamatergic transmission of prefrontal cortex-NAc synapses and the
strength of hippocampus-NAc synapses of mice expressing depression-like behavior following
CSDS (Bagot et al., 2015; LeGates et al., 2018). Due to this evidence, enhancing activity in MSNs
may result in resilient behavior while diminishing MSNs may result in anxiety-like behavior
following CSDS (Francis & Lobo, 2017). A decrease in MSN dendrites following viral
overexpression of RPRD2 may be observed should these mice not show resilience.
I hypothesized that mice with increased levels of RPRD2 in the NAc will display less
anxiety-like behavior, will yield decreased phosphorylation of S5p on RNA polymerase II, and
will demonstrate increased medium spiny neuron morphology following a period of chronic
social defeat stress. Furthermore, utilized RNA sequencing approaches identified the gene loci
most sensitive to RPRD2-mediated inhibition of RNA polymerase II function. In discerning the
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transcriptional impact of RPRD2 overexpression with the RNA sequencing data, RPRD2 may be
targeted in order to develop effective pharmacotherapies for those with anxiety disorders.
Following a description of the materials and methods utilized in this study, I will outline the
data collected and discuss the implications of the results in this study.
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Materials and Methods
Animal Husbandry

Adult male 8–10-week-old C57BL/6J mice and male 4–6-month-old CD1 retired breeder
aggressor mice from Jackson Laboratories were housed at 22-25 °C in a 12-hour light/dark
cycle. The animals were provided food and water as needed. C57BL/6J mice were paired in
groups of five same-condition (HSV-RPRD2 or HSV-GFP) static cages for the duration of the
study (Bailey & Crawley, 2009). CD1 mice were housed individually in static cages. All studies
were conducted in accordance with the Institutional Animal Care and Use Committee
regulations at Virginia Commonwealth University School of Medicine.

Stereotaxic Surgery

RPRD2 had been successfully gateway cloned in p1005 plasmid and packaged in Herpes
Simplex Virus (HSV) by Hannah Woolard, another Master’s student in the Hamilton Lab, for
further use. Stereotaxic surgery was conducted in order to virally inject HSV-RPRD2 or HSV-GFP
into the NAc of mice. Mice were anesthetized with a Ketamine/Xylazine mixture (100 mg/kg
Ketamine and 5 mg/kg Xylazine dissolved in sterile normal saline) injected into the peritoneum.
The eyes were covered with an ocular lubricant to prevent dryness during the surgery. Mice
were securely placed on clean stereotaxic instruments with the skull surface exposed; the
instruments were routinely sterilized with 70% acetone, and the syringes (5 μL Microliter
Syringe Model 85 RN, Small Removable Needle, 26s gauge, 2 in, point style 2) were sterilized
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with 100% acetone and PBS. Betadine antiseptic was applied to the top of the head using sterile
cotton swabs and a middle incision was made with a disposable razor. The tip of the syringes
were positioned at Bregma, an anatomical landmark on the rodent’s skull. The x, y, and z
coordinates were zeroed out on a digital Vernier scale to set Bregma as an origin point in
respect to all other coordinates. To locate the NAc, the syringes were positioned to precalculated anterior/posterior and medial/lateral coordinates at +1.6 and -1.5/+1.5 respectively
(Franklin & Paxinos, 2019). The area of the skull directly under the syringe tips was drilled using
a dental drill with a 0.6 mm burr. 1 µL of the virus (viral aliquots stored in a -80 °C freezer,
transported on dry ice, and kept on wet ice when in use) was acquired and the syringes were
lowered to the dorsal/ventral coordinate at -4.4. The viral solution was delivered at a rate of 0.2
µL per minute and syringes were held for five minutes following delivery to allow the virus to
diffuse. The syringes were slowly raised out of the skull and the animal was removed from the
stereotaxic instrument. The incision was closed via tissue adhesive. Animals were placed in a
clean cage warmed on an IR heating pad during recovery from the anesthesia. The heating pad
was removed and the mice given one day to acclimate before experiencing chronic social defeat
stress. This process was conducted with the aid of Joey Picone, Natalie Truby, Gabriella Silva,
and Kijoon Kim: graduate students in the Hamilton lab who were trained on this procedure.

Chronic Social Defeat Stress

A Chronic Social Defeat Stress (CSDS) protocol was implemented to establish anxiety-like
behavior in cohorts of 20 mice (Golden et al., 2011). Although a standard CSDS protocol from
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previous studies occurs for 10 minutes, twice a day, for 10 days, an accelerated CSDS protocol
was chosen for this experiment as HSV target and expression in neurons is only evident for 3-7
days. As a control to negate stress as a factor, the first cohort did not experience CSDS. The
second cohort of mice experienced CSDS for 10 minutes, twice a day, for 5 days. The third and
fourth cohort experienced a more aggressive CSDS for 11 minutes, twice a day, for 6 days in
order to further power the results and more closely mimic the standard CSDS protocol. The fifth
cohort also did not experience CSDS (Figure 1). C57BL/6J mice were individually housed in static
cages with a perforated divider. To experience physical stress, the C57BL/6J mice were exposed
to a novel CD1 aggressor mouse on the same side of the perforated divider for an allotted
duration. Following CSDS, the C57BL/6J mice were transferred to the other side of the
perforated divider to stimulate sensory stress from the neighboring CD1 mouse. The C57BL/6J
mice encountered a novel CD1 mouse for each defeat. This process was conducted both by
myself and with the aid of Hannah Woolard.

Behavioral Testing

Behavioral testing was conducted 24 hours after the final CSDS. Behavioral testing
consisted of a social interaction test and an elevated plus maze test. From the social interaction
test, heat maps and thigmotaxis data were acquired. Behavioral testing was conducted under a
red light, and video recorded and tracked using Ethovision XT. The first cohort (No CSDS)
consisted of nine HSV-GFP mice and eight HSV-RPRD2 mice, the second cohort (5 Day CSDS)
consisted of nine HSV-GFP mice and nine HSV-RPRD2 mice, the third cohort (6 Day CSDS)
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consisted of seven HSV-GFP mice and seven HSV-RPRD2 mice, the fourth cohort (6 Day CSDS)
consisted of two HSV-GFP mice and three HSV-RPRD2 mice, and the fifth cohort (No CSDS)
consisted of two HSV-GFP mice and two HSV-RPRD2 mice. The following processes were
conducted both by myself and with the aid of Hannah Woolard.

Social Interaction Test

A social interaction (SI) test was conducted to measure social behavior (File & Hyde,
1978). First, a C57BL/6J mouse was allowed to freely explore a 53 x 53 cm arena with walls 43
cm high containing an empty plexiglass wire mesh cage against one wall of the arena for 2.5
minutes. The mouse was removed and the arena cleaned with 70% ethanol. Then, a novel CD1
aggressor mouse was placed in the plexiglass wire mesh cage. The same C57BL/6J mouse was
placed in the center of the arena for 2.5 minutes to test time spent in the interaction zone (18 x
25 cm) during sensory exposure to the aggressor mouse. The same CD1 aggressor mouse was
used for each arena to provide consistent social interaction.

Elevated Plus Maze Test

Immediately after the SI test, an elevated plus maze (EPM) test was conducted to
further measure anxiety-like behavior (Bailey & Crawley, 2009; Kraeuter et al., 2019; Rodgers &
Dalvi, 1987). The EPM arena was elevated off of the floor (63.5 cm high) and consisted of two
opposite open arms crossed by two opposite closed arms with a center area at the crossing. A
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C57BL/6J mouse was placed in the center area and allowed to explore the arena for five
minutes to assess time spent in the open arms (each arm was 38 cm long). The mouse was
removed and the arena cleaned with 70% ethanol.

Thigmotaxis

Thigmotaxis was measured using the SI test data to determine the tendency of mice to
remain close to the walls, indicating increased fear or anxiety with decreased time spent in the
center zone (17 x 32 cm) (Simon et al., 1994).

Tissue Collection

Following rapid decapitation, brains were removed and sectioned into 1 mm coronal
slices using brain matrices. Using two 14-gauge punches under a fluorescent light, bilateral NAc
tissue samples were extracted, placed into individual Eppendorf tubes (1.5 mL), frozen on dry
ice, and stored in a -80 °C refrigerator until Western Blots were conducted. Tissue collection
was conducted with the aid of Joey Picone, Natalie Truby, Gabriella Silva, and Kijoon Kim.

Western Blot

Western Blots were conducted to measure levels of protein in the tissue samples
collected. 200 μL of ice-cold RIPA buffer was added to the sample in the 1.5 mL Eppendorf tube
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(Bio-Rad Laboratories, Inc., n.d.). Samples were homogenized with battery-operated mortar
and pestle with sterile blue tips until no tissue pieces were apparent and sonicated for 3 cycles
of 20 seconds on wet ice in a cold room (BioRuptor: 120w). The probe was rinsed with 70%
ethanol and dried with Kim wipes between each sample. The tubes were shaken on Effendorf
ThermoMixer at 4°C and 300 rpm for 30 minutes, and then centrifuges at 14,000 rpm at 4 °C for
15 minutes. 170 μL of the supernatant was transferred to a new 1.5 mL Eppendorf tube and the
rest was saved in the -80 °C refrigerator. Total protein levels were determined using a
proprietary colorimetric detection reagent (Pierce660 nm Protein Assay Kit). Sample
concentrations were normalized with RIPA buffer, mixed with equal amounts of 2x Laemmli
buffer, and pipetted up and down 20 times to mix. 60 μL of the sample was aliquot in a 1.5 ml
Eppendorf tube. Under a hood, 5 μL of bME was added to the sample and mixed 10 times. The
sample was heated at 95 °C for 5 minutes and then vortexed (medium speed, 2000 rpm, 30
seconds). TGX stain free gel (BIO-RAD; catalog number 5678094) were assembled and the tank
filled with a 10:1 ratio of deionized water and 10x Tris/Glycine/SDS buffer. 15 μL of each sample
and 10 μL of the well standards (Precision Plus Protein Unstained Standards and Precision Plus
Protein Kaleidoscope) were loaded into the gel which was run at 100 V for 2 hours. The gel was
transferred onto a membrane using the Transblot Turbo Packs (BIO-RAD; catalog number
1704157, high molecular weight, 2.5A constant, up to 25 V, 10 minutes). A stain-free gel image
was obtained using the ChemiDoc MP Imaging System. The membrane was placed in 50 mL of
blocking buffer (7% milk/TBST) and rocked on a rocking platform at room temperature for 1
hour. The buffer was removed and the membrane washed twice with TBST. The primary
antibody was placed to cover the membrane and rock overnight at room temperature [Goat
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pAb to RPRD2 50 ug (1 mg/mL), Ab10363, Primary Ab 1:2000/2.5% BSA, 17 μL and 35 mL]. The
following day, the membrane was washed with TBST and rocked in TBST for 10 minutes at room
temperature three times. 5 μL of the secondary antibody [Dnk pAb to Goat IgG (HRP) 500 ug (2
mg/mL), Ab205723, Secondary Ab 1:10000] was diluted in 50 mL of 2.5% milk and rocked at
room temperature for 1 hour. The membrane was washed five times with TBST for 10 minutes.
The membrane was placed in 10 mL of Clarity ECL substrate kit components (BIO-RAD; catalog
number 170-5060), and a chemiluminescent and calorimetric image was obtained using the
ChemiDoc MP Imaging System. The membrane was rinsed in TBST and unblocked with 5% milk
at room temperature for 1 hour. The membrane was rinsed again with TBST twice before
another primary antibody was added and the method repeated using antibodies for GFP, βactin, RNA Polymerase II Phospho Serine 5 [RNA polymerase II CTD repeat YSPTSPS (phospho
ser5), Ab5131, Primary Ab 1:1000/2.5%BSA, 35 μL and 35 mL], and RNA Polymerase II (RNA
polymerase II CTD repeat YSPTSPS, Ab26721, Primary Ab: 1:1000/2.5%BSA, 35 μL and 35 mL)
with 2.5% bovine serum albumin (BSA)/TBST as the blocking buffer. Band intensity was
quantified in Image Lab software and normalized to β-actin. Western blots were conducted
both by myself and with the aid of Xiaohong Cui and Hannah Woolard.

RNA Sequencing

RNA Sequencing was conducted to determine the gene loci regulated by RPRD2. 10
tissue samples (5 HSV-RPRD2 and 5 HSV-GFP) from the third cohort (6 Day CSDS) were shipped
to Genewiz (San Diego, CA) for RNA sequencing (Genomics from Azenta Life Sciences, n.d.).
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High-throughput next-generation sequencing was used to enable RNA analysis through the
sequencing of complementary DNA (Kukurba & Montgomery, 2015). The RNA sequence library
was isolated by first conducting mRNA enrichment, mRNA fragmentation, and random priming
(Genomics from Azenta Life Sciences, n.d.). Next, the tissue strands were synthesized into
complementary DNA. The fragmented DNA was then exposed to end repair, 5’
phosphorylation, and dA-tailing. An adaptor was ligated to the adenine base overhang of the
DNA fragments and a polymerase chain reaction amplification was performed to amplify the
sequences (Kukurba & Montgomery, 2015). Sequence quality was evaluated and the reads
were trimmed to remove low quality adaptor sequences and nucleotides (Genomics from
Azenta Life Sciences, n.d.). The sequence reads were then mapped to the Mus Musculus
GRCm38 reference genome available on ENSEMBL using the STAR aligner v.2.5.2b–a splice
aligner that detects splice junctions and incorporates them to read sequences. Unique gene hit
counts were calculated using featureCounts from the Subread package v.1.5.2 in order to count
unique reads that fell within exon regions. After extraction, the gene hit counts were used for
downstream differential expression analysis. Using differential gene expression (DESeq2), a
comparison of gene expression between the provided tissue samples was performed. A volcano
plot was assembled in Graphpad Prism 9 using the 𝑙𝑜𝑔2(fold change) of the normalized mean
hit counts for the gene and the -𝑙𝑜𝑔10(Wald test P value) where the nominal p-value = 1.85. This
process was conducted with the aid of Dr. Peter Hamilton.

Gene Ontology Analysis
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A gene ontology analysis was conducted to analyze the biological processes affected by
RPRD2. WebGestalt (WEB-based Gene SeT AnaLysis Toolkit), a functional enrichment analysis
web tool, matched RPRD2 upregulated and downregulated gene transcripts to their
corresponding function using the Benjamini-Hochberg false discovery rate < 0.05. Each
geographic process was represented by the fold enrichment and portrayed geographically using
Rstudio in which each plot point was colored by the -𝑙𝑜𝑔10(FDR P value) and sized by the
number of corresponding genes. Gene Ontology analysis was conducted with the aid of Dr.
Peter J. Hamilton and Kijoon Kim. Additionally, DropVis, a droplet-based single-cell RNA-seq,
was used to determine discrete cell clusters that were highly enriched by RPRD2 upregulated
and downregulated genes.

Perfusion

Perfusion was conducted on the fourth (6 Day CSDS) and fifth cohorts (No CSDS)
following the SI and the EPM tests to fix the brain tissue. 0.3 mL of ketamine was administered
in the abdominal cavity to induce anesthesia. 20-gauge 5 BD PrecisionGlide needles held down
the rodent’s paws and rib cage on an elevated styrofoam lid. A Scalp Vein Set attached to an
Ismtec Masterflex Perfusion pump (4.8 mL/min) was injected into the rodent’s left ventricle and
the rodent was perfused with PBS until its liver lightened in color. The right atrium was snipped
to allow blood flow. Then, PFA (32% stock EMgrade paraformaldehyde, diluted to 4%) was
perfused until the rodent was rigid. Lastly, the system was flushed with PBS and the tools
cleaned in 70% ethanol. The brain was extracted and refrigerated in a 5 mL Eppendorf tube
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with 2.5 mL of PFA for 48 hours. Following this, the brain was transferred to a 15% sucrose
solution (15% sucrose in 1x PBS and 0.05% sodium azide) for 24 hours, a 30% sucrose solution
(30% sucrose in 1x PBS and 0.05% sodium azide) for 24 hours, and a 30% sucrose solution for
another 24 hours. Perfusions were conducted with the aid of Kijoon Kim.

Medium Spiny Neuron Morphology

Medium spiny neuron (MSN) morphology was conducted on Cohorts 4 (6 Day CSDS) and
5 (No CSDS) to analyze dendritic spine changes caused by RPRD2. Brain tissue was sliced on a
brain block with disposable single edge industrial razor blades in order to become nearer to the
NAc (ImageJ Wiki, n.d.). Sekundenkleber instant adhesive was used to glue the brain onto the
platform of a Leica VT1000S Vibratome and positioned so that the dorsal side of the brain faced
away from the bystander. The area of the NAc was estimated, and roughly the prefrontal cortex
and cerebellum were sliced away before tissue sectioning. The remaining brain was placed in
PBS so that it was covered entirely and a personna super blade was used to slice 40 μm of
tissue. A paint brush was used to capture each slice and set each NAc section of the brain on a
RITE-ON micro slide (3 x 1 in, 1.1-1.3 mm thick). Once the sections dried on the slide, each
tissue slice was covered with one drop of NucBlue Fixed Cell Stain ReadyProbes reagent and
each slide was covered with ProLong Glass Antifade Mountant (about 10 slices per slide, 2-3
slides per brain). Any remaining brain sections were removed with acetone. The slides were
placed in a 4°C refrigerator overnight and imaged the next day with Keyence BZ-X810.
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Immersion oil type HF was used for magnifications 60x or higher. MSN morphology was
conducted on tissue samples that had the most fluorescence and clarity, as they indicated the
best targeted NAc during stereotaxic surgery. Selection criteria also included the ability to
observe dendrites and not simply a tract of axons. The selected tissue samples were chosen
with the aid of Natalie Truby, who was intimately familiar with the NAc, but an objective
bystander in regard to this experiment. Neurons were traced in (Fiji Is Just) ImageJ.

Statistical Analysis

Data were analyzed using GraphPad Prism Software. Three-way Analysis of variance
(ANOVA) and two-tailed unpaired t tests were run to compare the results of the SI test,
thigmotaxis, and EMP test within groups (p ≤ 0.05).
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Results

As stated above, the first cohort of mice did not experience CSDS to act as a control
cohort and to understand the consequence of HSV-RPRD2 delivery to the NAc in the absence of
stress (Figure 1.A). The second cohort of mice experienced CSDS for 10 minutes, twice a day,
for 5 days (Figure 1.B). The third (Figure 1.C) and fourth (Figure 1.D) cohort experienced CSDS
for 11 minutes, twice a day, for 6 days. NAc tissue samples from the third cohort were
processed for RNA sequencing. Data from the fourth cohort was originally intended to conduct
MSN morphology; however, too much time may have passed between viral delivery of RPRD2
and the analysis of the tissue which led to GFP no longer being visible. Despite this, behavioral
analysis was still conducted and used to further power the results. The fifth cohort did not
experience CSDS and was instead used for MSN morphology analysis (Figure 1.E).
To confirm that HSV-RPRD2 was indeed virally overexpressed in MSNs of the NAc, a
Western blot was conducted retroactively on the membranes obtained from mice in Cohort 1
(No CSDS) and Cohort 2 (5 Day CSDS). This study is still ongoing in order to achieve significant
results and confirm the relative expression of HSV-RPRD2 in comparison to HSV-GFP. This
process is led by Hannah Woolard.

Social behavior was not significantly impacted by RPRD2.

A social interaction (SI) test was conducted to measure social behavior of mice with viral
overexpression of RPRD2 in the NAc both in the absence and in the presence of a novel CD1
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mouse (File & Hyde, 1978). Social behavior was quantified by the seconds a male C57BL/6J
mouse spends in the 18 x 25 cm dimensions of the interaction zone of an SI area; less time
spent in the interaction zone in the presence of a novel CD1 mouse indicates a decrease in
social behavior.
Overall, one-way ANOVA did not show a significant effect on the time spent in the
interaction zone of an SI test. Unstressed RPRD2 mice in Cohort 1 (No CSDS) in the presence of
an aggressive CD1 male mouse did not spend a significant amount of time in the interaction
zone (p = 0.7950) in comparison to GFP mice (Figure 2.A). Amongst stressed mice from Cohort 2
(5 Day CSDS), Cohort 3 (6 Day CSDS), and Cohort 4 (6 Day CSDS), the same effect was observed
(p = 0.6896) (Figure 2.B). Data from the first four cohorts were combined and no significant
difference was observed between the RPRD2 and GFP mice (p = 0.5732), regardless of an
aggressor CD1 mouse (Figure 2.C). Collectively, this data indicates that viral overexpression of
RPRD2 within the NAc of unstressed or stressed mice does not impact social behavior.

Increased levels of RPRD2 indicates an increase in anxiety-like behavior in male mice.

Elevated plus maze (EPM) test was conducted to specifically measure anxiety-like
behavior in mice with viral overexpression of RPRD2 (Bailey & Crawley, 2009; Kraeuter et al.,
2019; Rodgers & Dalvi, 1987). Less time spent in the open arms of the EPM–and thus more time
in the closed arms–over the course of 5:00 minutes correlates with increased physiological
stress and anxiety-like behavior.
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From this paradigm, unpaired t tests showed a significant effect on time spent in the
open arms of an EPM test between stressed RPRD2 and GFP mice. Without exposure to chronic
stress, unpaired t tests did not reveal a significant effect on time spent in the open arms for
mice in Cohort 1 (No CSDS) (Figure 3.A); however, a downward trend was observed in which
RPRD2 mice spent less time in the open arms than GFP mice (p = 0.2042). Data from chronically
stressed RPRD2 mice in Cohort 2 (5 Day CSDS), Cohort 3 (6 Day CSDS), and Cohort 4 (6 Day
CSDS) did portray significantly less time in the open arms (p = 0.0484) than GFP mice (Figure
3.B). In combining Cohorts 1-4 EPM data, RPRD2 mice spent significantly less time in the open
arms (p = 0.0169) than did GFP mice, indicating anxiety-like behaviors in mice virally
overexpressed with RPRD2 (Figure 3.C).
To further enforce the importance of the results of the EPM paradigm, thigmotaxis was
retroactively measured using the SI test data to determine the tendency of mice to remain
close to the walls. Decreased time spent in the center zone of the SI arena (17 x 32 cm) in the
absence of an aggressor CD1 mouse indicated increased fear or anxiety (Simon et al., 1994). In
general, one-way ANOVA did not show a significant effect on thigmotaxis. Unstressed RPRD2
mice in Cohort 1 (No CSDS) did not spend a significantly different amount of time in the center
zone (p = 0.8041) in the absence of an aggressor CD1 mouse in comparison to GFP mice (Figure
4.A). Data from chronically stressed RPRD2 mice in Cohort 2 (5 Day CSDS), Cohort 3 (6 Day
CSDS), and Cohort 4 (6 Day CSDS) did display a trend of less time spent in the center zone (p =
0.1130) in comparison to the GFP mice; however, significance was not attained (Figure 4.B). In
combining Cohorts 1-4 EPM data, RPRD2 mice spent less time in the center zone (p = 0.1247) in
comparison to the GFP mice (Figure 4.C). This trend of increased thigmotaxis seen further

34

supports anxiety-like behaviors in mice virally overexpressed with RPRD2, but must be
cautiously interpreted as the behavioral effect did not reach significance.

The impact of RPRD2 on RNA polymerase II phospho ser5 levels.

After quantifying the behavioral impact of RPRD2 overexpression, the molecular impact
of RPRD2 was quantified by assessing levels of RNA polymerase II phospho ser5. As RPRD
proteins were implicated in decreasing phosphorylation of serines at position 5 of the carboxylterminus domain of RNA Polymerase II, heightened levels of RPRD2 protein might lower levels
of phospho ser5 and would further connect these results to a decrease in transcriptional
activity in this brain area.
Overall, unpaired t tests did not show a significant effect in RNA polymerase II phospho
ser5 activity, indicated by the normalization factor. The normalization factor was calculated by
dividing the RNA polymerase II phospho ser5 adjusted total band volume–from the Western
blot images–by the β-actin adjusted total band volume (Figure 5.A). The HSV-RPRD2
normalization factor values in each membrane were averaged and set as 1 for the data set to
allow comparison between membranes.
Although no significance was reached, tissue samples from unstressed RPRD2 mice in
Cohort 1 (No CSDS) did reveal slightly decreased levels of RNA polymerase II phospho ser5 (p =
0.3287) in comparison to the GFP mice (Figure 5.B). Stressed RPRD2 mice in Cohort 2 (5 Day
CSDS) also revealed a similar, stronger trend (p = 0.2712) (Figure 5.C). Cohort 3 (6 Day CSDS)
data was unavailable as the tissue samples were sent for RNA sequencing, and Cohort 4 (6 Day
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CSDS) data was unavailable as the tissue samples were unsuccessfully used to analyze MSN
morphology. Additionally, Cohort 1 (No CSDS) and Cohort 2 (5 Day CSDS) combined
normalization factor data (p = 0.0745) revealed a strong downward trend in levels of RNA
polymerase II phospho ser5 for RPRD2 mice in comparison to GFP mice (Figure 5.D). While our
individual cohorts were likely not powered sufficiently to detect a significant decrease in RNA
polymerase II phospho ser5 levels mediated by viral overexpression of RPRD2, combining these
cohorts enabled more robust detection of the regulatory role of RPRD2 on RNA polymerase II.
These data suggest that RPRD2 likely does act to dephosphorylate serines at position 5 on the
CTD of RNA polymerase II in the neurons of the NAc, though further analyses will be required to
achieve a significant result.
Total levels of RNA polymerase II were measured to determine the total effect RPRD2
may have on the CTD on RNA polymerase II. Measuring the total RNA polymerase II via a
Western blot proved difficult as its molecular mass was very similar to that of RNA Pol II
phospho ser5 (220 kD for the former, 250 kD for the latter). Despite this, the normalization
factor was calculated by dividing the RNA polymerase II adjusted total band volume–from the
Western blot images–by the β-actin adjusted total band volume (Figure 6.A). The HSV-RPRD2
normalization factor values in each membrane were averaged and set as 1 for the data set to
allow comparison between membranes.
Tissue samples from unstressed RPRD2 mice in Cohort 1 (No CSDS) did not show a
significant effect on total RNA polymerase II levels (p = 0.7598) in comparison to the GFP mice
(Figure 6.B). Stressed RPRD2 mice in Cohort 2 (5 Day CSDS) did reveal a slight downward trend
of RNA polymerase II levels, but the trend was not significant (p = 0.1488) (Figure 6.C). Cohort 3
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(6 Day CSDS) data was unavailable as the tissue samples were sent for RNA sequencing, and
Cohort 4 (6 Day CSDS) data was unavailable as the tissue samples were unsuccessfully used to
analyze MSN morphology. Combined normalization factor data from Cohort 1 (No CSDS) and
Cohort 2 (5 Day CSDS) did not reveal significance (p = 0.4370) (Figure 6.D). These data suggest
that the observed effect of RPRD2 decreasing phosphorylation of the CTD of RNA polymerase II
is not due to changes in the total amount of RNA polymerase II, and further solidifies its effect
on the dephosphorylation of serine at position 5 on the CTD of RNA polymerase II in the
neurons of the NAc.

RPRD2 primarily impacts genes that are typically highly enriched in fibroblast and ependymal
cell types.

We next explored the molecular impact of RPRD2 on transcription in the NAc. We
hypothesized that RPRD2 may regulate the expression of key gene loci via its
dephosphorylation and subsequent regulation of RNA polymerase II. Tissue samples from
Cohort 3 (6 Day CSDS) were subjected to RNA sequencing (see Methods) and DEGs were
generated across the HSV-RPRD2 and HSV-GFP groups to explore the gene loci potentially
regulated by RPRD2. A volcano plot was assembled and analyzed (nominal p-value threshold set
to = -𝑙𝑜𝑔10(1.85)) (Figure 7). RPRD2 upregulated genes were colored yellow, and RPRD2
downregulated genes were colored blue.
The most significantly upregulated gene identified was Slc47a1. DropVis data revealed
that this gene, as well as many other upregulated DEGs, is highly enriched in fibroblast cells
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(Figure 8.A). Contrastingly, many dynein-related genes were significantly downregulated, such
as Dnah12. Using the gene loci identified through the RNA sequence, DropVis data revealed
that RPRD2 primarily downregulates genes highly enriched in ependymal cells (Figure 8.B).
Given that HSVs exclusively infect neurons, it is unclear whether viral overexpression of RPRD2
in NAc neurons indirectly induces these DEGs within the aforementioned non-neuronal cell
types or if RPRD2 is directly responsible for regulating these DEGs in the infected neurons,
which under basal conditions are enriched in fibroblast or ependymal cells.

RPRD2 may decrease microtubule transport in neurons within the NAc.

Using the genes identified from the RNA sequencing data, a gene ontology analysis was
conducted to analyze the biological processes affected by overexpression of RPRD2. GO overrepresentation analysis revealed that the common upregulated GO terms were related to
extracellular matrix organization, tube development, and embryo development (Figure 8.C). GO
over-representation analysis also revealed that the common downregulated GO terms were
related to microtubule-based movement, cilium organization, and organelle assembly (Figure
8.D). Amongst all terms, microtubule-based movement had the highest Fold Enrichment Value
and the most red -𝑙𝑜𝑔10(FDR P value).

RPRD2 may decrease dendritic branches of MSNs in the NAc.
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We hypothesized that viral delivery of RPRD2 to the NAc would decrease transcription
at key genes, and we identified microtubule-related genes as the top downregulated
transcripts. We next aimed to explore what consequence this might have on the cellular
morphology of MSNs, the principle neuronal cell-type in the NAc. MSN morphology was
observed by viewing the amount of neuronal dendritic branching. We hypothesized that
diminished MSNs may indicate susceptible, anxiety-like behavior in mice following CSDS. Upon
observing images of MSNs in the NAc of mice from Cohort 5 (No CSDS) in (Fiji Is Just) ImageJ, it
appeared that there was less dendritic branching in neurons injected with viral overexpression
of HSV-RPRD2 (Figure 9.A) than those with HSV-GFP (Figure 9.B). However, this is a preliminary
observation and further analysis is needed to definitively determine the significance of this
observation.
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Figure 1.
A.

B.

C.

D.

E.

Figure 1: Timeline of the Chronic Social Defeat Stress for each cohort.
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Figure 2.
A.

B.

C.

Figure 2: Amongst all cohorts, time spent in the interaction zone during the SI test did not yield
statistically significant results. A) With or without the presence of a CD1 aggressor mouse, the
groups within Cohort 1 (No CSDS) did not portray a significant difference in the time spent in
the interaction zone. B) Stressed mice in Cohort 2 (5 Day CSDS), Cohort 3 (6 Day CSDS), and
Cohort 4 (6 Day CSDS) did not significantly reveal a difference in time spent in the interaction
zone. C) All mice across Cohorts 1-4 did not portray a significant difference in the time spent in
the interaction zone within the groups. Symbols represent mean ± SEM.
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Figure 3.
A.

B.

C.

Figure 3: Amongst mice exposed to CSDS, time spent in the open arms of the EPM revealed a
downward trend. A) Unstressed mice with overexpression of RPRD2 in Cohort 1 (No CSDS)
spent less time in the open arms of the EPM than GFP mice, but the trend is not significant. B)
Stressed RPRD2 mice in Cohort 2 (5 Day CSDS), Cohort 3 (6 Day CSDS), and Cohort 4 (6 Day
CSDS) revealed significantly less time spent in the open arms than GFP mice. C) All RPRD2 mice
across Cohorts 1-4 displayed significantly less time spent in the open arms than GFP mice.
Symbols represent mean ± SEM.
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Figure 4.
A.

B.

C.

Figure 4: Amongst all cohorts, thigmotaxis yielded a downward trend in stressed mice with viral
overexpression of RPRD2. A) Unstressed mice with viral overexpression of RPRD2 in Cohort 1
(No CSDS) did not reveal a significant difference in the amount of time spent in the center zone
in the absence of a CD1 aggressor mouse in comparison to GFP mice. B) Stressed RPRD2 mice in
Cohort 2 (5 Day CSDS), Cohort 3 (6 Day CSDS), and Cohort 4 (6 Day CSDS) revealed a trend of
less time spent in the center zone in comparison to GFP mice. C) All RPRD2 mice across Cohorts
1-4 displayed a downward trend of time spent in the center zone in the absence of a CD1
aggressor mouse in comparison to GFP mice. Symbols represent mean ± SEM.
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Figure 5.
A.

B.

C.

D.

Figure 5: Normalized RNA Polymerase II Phospho Ser5 levels revealed a downward trend in
RPRD2 mice. A) A representative blot of RNA Polymerase II Phospho Ser5 levels showed less
Ser5p (lighter band on Western blot) in RPRD2 mice than GFP mice. B) Unstressed RPRD2 mice
of Cohort 1 (No CSDS) revealed a downward trend of Ser5p levels in comparison to GFP mice. C)
Stressed RPRD2 mice of Cohort 2 (5 Day CSDS) revealed a downward trend of Ser5p levels. D)
All mice with viral overexpression of RPRD2 in Cohorts 1-2 revealed a downward trend in Ser5p
levels, but no significance was reached. Symbols represent mean ± SEM.
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Figure 6.
A.

B.

C.

D.

Figure 6: Normalized RNA Polymerase II levels revealed a downward trend in RPRD2 mice. A) A
representative blot of total RNA polymerase II levels showed less RNA polymerase II (lighter
band on Western blot) in RPRD2 mice than GFP mice. B) Unstressed RPRD2 mice of Cohort 1
(No CSDS) revealed a downward trend of RNA polymerase II levels in comparison to GFP mice.
C) Stressed RPRD2 mice of Cohort 2 (5 Day CSDS) revealed a downward trend of RNA
polymerase II levels. D) All mice with viral overexpression of RPRD2 in Cohorts 1-2 revealed a
downward trend in RNA polymerase II levels, but no significance was reached. Symbols
represent mean ± SEM.
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Figure 7.

Figure 7: Volcano plot from RNA sequence displaying RPRD2 upregulated (yellow) and
downregulated (blue) genes.
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Figure 8.
A.

C.

B.

D.

Figure 8: Male mice with RPRD2 overexpression displayed distinct upregulated and
downregulated targets. A) Pie chart depicting discrete cell clusters that were highly enriched by
RPRD2 upregulated genes. B) Pie chart depicting discrete cell clusters that were highly enriched
by RPRD2 downregulated genes. C) Visualization of key gene ontology functions among the
upregulated RPRD2 gene list. D) Visualization of key gene ontology functions among the
downregulated RPRD2 gene list.
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Figure 9.
A.

B.

Figure 9: HSV-RPRD2 MSNs appear to be less branched than HSV-GFP MSNs. A) Image of RPRD2
MSN. B) Image of GFP MSN.
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Discussion

Anxiety-like behavior following increased levels of RPRD2

Earlier work from our laboratory identified RPRD2 differentially expressed in the brain of
mice stratified in terms of their phenotypic response to chronic stress (Hamilton et al., 2020).
RPRD2 protein was elevated in the NAc of stress resilient animals–mice that display less
behavioral abnormalities and more successful adaptation to stressors. To test social behavior, a
social interaction test was conducted; less time spent in the interaction zone in the presence of
an aggressor CD1 mouse indicates a decrease in social behavior (File & Hyde, 1978). As seen in
the figures above, social interaction was not affected by chronic social defeat stress following
elevated levels of RPRD2. There were no significant differences in time spent in the interaction
zone between groups. Therefore, viral overexpression of RPRD2 within the NAc of unstressed or
stressed mice did not impact social behavior.
Behavioral data was also collected from an EPM test. The EPM test is a well-established
paradigm measuring anxiety-like behavior in mice (Bailey & Crawley, 2009). This test takes
advantage of mice’s natural tendency to avoid open areas. Less time spent in the open arms of
the EPM–and thus more time in the closed arms–correlates with increased physiological stress.
As seen in the data above, stressed C57BL/6J mice, and not unstressed C57BL/6J mice, with
viral overexpression of RPRD2 spent significantly less time in the open arms of the EPM than did
GFP mice. This indicated that elevated levels of RPRD2 specifically engendered stress-induced
anxiety-like behavior.
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Distance (cm) and velocity (cm/s) moved in the EPM paradigm was also assessed to
determine if the decreased time spent in the open arms was associated with reduced
locomotion in general amongst mice with viral overexpression of RPRD2 in comparison to the
control. Reduced locomotion could indicate that RPRD2 mice chose a location in the EPM and
remained in that location for the remaining testing period. Data collected revealed that
unstressed and stressed RPRD2 and GFP mice moved roughly equal distances and at equal
velocity (not shown). Thus, RPRD2 mice expressed no change in locomotion in comparison to
GFP mice, and truly spent less time in the open arms of the EPM.
To further explore RPRD2’s correlation to anxiety-like behavior, thigmotaxis was
retroactively measured using the SI test data to determine the tendency of mice to remain
close to the walls. Decreased time spent in the center zone in the absence of an aggressor CD1
mouse indicated increased fear or anxiety (Simon et al., 1994). Specifically, chronically stressed
mice with viral overexpression of RPRD2, and not unstressed mice, revealed a downward trend
of less time spent in the center zone. This trend of increased thigmotaxis upon exposure to
chronic stress indicates anxiety-like behaviors in mice virally overexpressed with RPRD2, as well
as the results of the EPM test.
As discussed above, evidence suggests that resilient mice have higher levels of RPRD2
protein within the NAc in comparison to susceptible mice when exposed to CSDS (Hamilton et
al., 2020; Wendelmuth et al., 2020). However, the data presented above indicates that RPRD2
is associated with anxiety-related behaviors when mice are exposed to CSDS. Rejection of the
initial assumption of RPRD2’s behavioral role was prompted by the difference in the two
studies’ methodology. In the experiment conducted by Hamilton et al., the mice were exposed
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to stress and a proteomic analysis revealed elevated RPRD2 in the NAc (Hamiton et al., 2020).
However, the approach used in this experiment first began with viral overexpression of RPRD2,
then exposure to CSDS, and finally an analysis of the NAc. The varying sequence of events and
adjusted levels of RPRD2 could be underlying factors for the difference seen in the behavioral
role of RPRD2 in the NAc.
These collective novel findings suggest that viral overexpression of RPRD2 plays a role in
governing anxiety-related behaviors. This solicited further questions as to the mechanistic
impact of this protein in the NAc. In discerning the impact of RPRD2 overexpression with the
NAc, RPRD2 may be targeted in order to develop effective pharmacotherapies for those with
anxiety disorders. The molecular impact of viral overexpression of RPRD2 needed to be
investigated, which led to exploring the effect of RPRD2 on RNA Polymerase II Phospho Ser5
activity levels.

Effect of RPRD2 on S5p levels

RPRD proteins have been implicated in decreasing phosphorylation of serines at position
5 of the carboxyl-terminus domain of RNA Polymerase II. Heightened levels of RPRD2 protein
may lower levels of phospho ser5 and thus decrease transcriptional activity of RNA polymerase
II (Ni et al., 2011; Ali et al., 2019). Following a Western blot, RNA Polymerase II Phospho Ser5
levels (normalized to β-actin) revealed a strong downward trend in RPRD2 mice in comparison
to GFP mice and sufficient detection of the regulatory role of RPRD2 on RNA polymerase II. This
trend indicated that increased levels of RPRD2 decreased phosphorylation of serines at position
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5 on the CTD of RNA polymerase II in the neurons of the NAc, in accordance with my
hypothesis. This data is consistent with previous findings conducted on RPRD proteins.
Total levels of RNA polymerase II were measured as well to determine the total effect
RPRD2 may have on the CTD on RNA polymerase II. Measuring the total RNA polymerase II via a
Western blot proved difficult as its molecular mass was very similar to that of RNA Pol II
phospho ser5 (220 kD for the former, 250 kD for the latter). Between antibodies used to target
these variables, the membranes were thoroughly washed to avoid any band crossover or
residue from the previous target. These data suggest that RPRD2 does not appear to impact
total protein levels of RNA polymerase II, and further solidifies its effect on the
dephosphorylation of serine at position 5 on the CTD of RNA polymerase II in the neurons of
the NAc.
As stated above, increased levels of RPRD2 decrease phosphorylation of serines at
position 5 on the CTD of RNA polymerase II in the neurons of the NAc. This may induce
downstream effects on transcription of certain genes within the NAc and downregulate their
expression. Manipulation of even a single gene can profoundly affect behavior (Robinson et al.,
2008). Genome sequencing can detect genomic variation and aid in understanding how genetic
information influences brain circuits that mediate behavior (Robinson et al., 2008).

Primary cluster types and biological processes impacted by RPRD2

It has been previously shown that changes in the NAc can affect psychiatric disorders
such as anxiety disorders and a host of others (Mavridis, 2015). High-throughput next
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generation sequencing was conducted to enable RNA analysis in order to discern more exact
changes in the NAc and how those changes may be influencing those with anxiety-like behavior.
The most significantly upregulated gene identified was Slc47a1. DropVis data revealed
that this gene, as well as many other upregulated DEGs, is highly enriched in fibroblast cells.
Fibroblast cells can be found in perivascular spaces, meninges, and choroid plexus of the brain
and spinal cord (Dorrier et al., 2022). They provide structural support to connective tissues by
secreting extracellular matrix components, produce cytokines and growth factors, assist in
angiogenesis, and respond to mechanical stress by remodeling tissue. Contrastingly, many
dynein-related genes were significantly downregulated, such as Dnah12. Using the gene loci
identified through the RNA sequence, DropVis data revealed that RPRD2 primarily
downregulates genes highly enriched in ependymal cells. Ependymal cells are responsible for
transporting electrolytes between cerebral spinal fluid and brain parenchyma, and may
contribute to osmotic control through cotransporters (Daroff et al., 2014; Meunier & Spassky,
2020).
As stated previously, it is unclear whether viral overexpression of RPRD2 in NAc neurons
indirectly or directly induces these DEGs. Given that HSVs exclusively infect neurons, I predict
that viral overexpression of RPRD2 more likely indirectly regulates these DEGs enriched in
fibroblast or ependymal cell types by a secondary mechanism; yet, this prediction should be
explored more in the future.
A gene ontology analysis was conducted to further analyze the biological processes
affected by overexpression of RPRD2 in the NAc. GO over-representation analysis revealed that,
amongst all terms, microtubule-based movement was the biological process least likely due to
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chance, and thus most significant. This suggests that viral overexpression of RPRD2 regulates
key genes associated with microtubule transport, and downregulation of microtubule related
genes along neurons in the NAc may be an underlying mechanism contributing to the
development of anxiety disorders.

Changes in MSN morphology

Changes in microtubule expression have been implicated in neuropsychiatric disorders
(Marchisella et al., 2016). As microtubules are capable of polymerizing into dendritic spines,
and as microtubule-based movement is most significantly downregulated in neurons in the
NAc, this brings into question the role of RPRD2 in regulating dendritic complexity and function
of NAc MSNs (Dent, 2017). Previous studies revealed that diminished MSNs may indicate
susceptible, anxiety-like behavior in mice following CSDS (Francis & Lobo, 2017). MSN
morphology was observed by viewing the amount of neuronal dendritic branching with a
simple neurite tracer, and it appeared that there was less dendritic branching in neurons
injected with viral overexpression of HSV-RPRD2 than those with HSV-GFP.
Decreased dendritic spine density and dendritic arborization–branching at the end of a
nerve fiber–have been largely associated with neurological diseases, specifically with
depression and schizophrenia in response to chronic stress, both of which are comorbid with
anxiety disorders (Anxiety & Depression Association of America, 2021; Marchisella et al., 2016).
Loss of synapses due to these reduced arborizations leads to disrupted feedback loops and
reduced adaptation to stressors (Duman & Canili, 2015). Collectively, these findings indicate
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that decreased MSN morphology is associated with stressed-induced anxiety-like behaviors.
Thus, RPRD2-mediated regulation of RNA polymerase II phosphorylation may preferentially
affect genes involved in microtubule-based movement, which consequently inhibits the
dendritic complexity and function of NAc MSNs; yet, additional analysis is needed to definitively
confirm the decreased effect of viral overexpression of RPRD2 on MSN dendritic branching
within the NAc.

Future Aims and Conclusions

Further investigation is needed in order to fully understand the implications of this data.
Given that women are twice as likely to be affected with Generalized Anxiety Disorder, Panic
Disorder, and Specific Phobias as men, it is important to note that very different behaviors and
molecular pathways may be affected by RPRD2 in female mice than in male mice (Anxiety &
Depression Association of America, 2021). As seen in Herbison et al., medium to high chronic
stress exposure during adolescence predicted depression and anxiety symptoms in females,
and high stress in early stages of pregnancy contributed to male depression and anxiety
symptoms as well (Herbison et al., 2017). Therefore, female C57BL/6J mice should be invested
using the same conditions as the studied male cohorts.
Due to lack of time and resources, HSV was used as a viral vector to target neurons. An
accelerated defeat paradigm was conducted as HSV expression in neurons is only evident for 37 days. The ongoing study to confirm that HSV-RPRD2 was indeed virally overexpressed in
MSNs of the NAc should be concluded and the results analyzed. In the future, adeno-associated
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virus (AAV) may be used in order to virally deliver RPRD2 to the NAc. Following stereotaxic
surgery, expression of AAV-RPRD2 may be detectable anywhere from 1-4 weeks, allowing a full
10 days of CSDS (Stoica et al., 2013). Use of AAV would ensure RPRD2’s viral overexpression in
MSNs of the NAc when conducting behavioral tests and further power our results.
Although there appeared to be less dendritic branching in neurons virally overexpressed
with RPRD2, a Sholl analysis must be conducted in the future in order to solidify this
observation and reduce observer bias. A Sholl analysis can quantify neuronal dendritic
complexity and truly determine if MSN morphology was blunted due to viral overexpression of
RPRD2 (Binley et al., 2014). As MSN morphology was not seen with Cohort 4 (6 Day CSDS) due
to GFP no longer fluorescing, further investigation is needed in order to determine if both CSDS
and a MSN morphology can be conducted while maintaining the pervasiveness of RPRD2.
Previous studies have shown decreased glutamatergic transmission of prefrontal cortex-NAc
synapses and decreased strength of hippocampus-NAc synapses of mice expressing depressionlike behavior following CSDS (Bagot et al., 2015; LeGates et al., 2018). Thus, it would be
interesting to investigate how MSN morphology changes along those synapses after CSDS.
In regard to gene loci, further studies should be conducted to explore the connections
between RPRD2 and its upregulated and downregulated genes. Attention may be best placed
on genes expressed in fibroblast and ependymal cell types. An in-depth motif analysis may be
beneficial in order to predict transcription factor binding events and a mechanistic pathway for
RPRD2 in the NAc. Additionally, further analysis should be conducted to achieve a significant
effect on RPRD2’s dephosphorylation of serines at position 5 on the CTD of RNA polymerase II
in the neurons of the NAc.
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In conclusion, I expanded on previous studies conducted on male mice revealing that
resilient mice had higher levels of RPRD2 in the NAc than susceptible mice. The data presented
indicates that viral overexpression of RPRD2 impacts anxiety-like behavior. The data also
demonstrates a link between increased RPRD2 levels and decreased S5p levels, indicating a stall
in the transcription activity of RNA polymerase II. This RPRD2-mediated regulation of RNA
polymerase II phosphorylation may preferentially affect genes involved in microtubule
transport, which consequently inhibits the dendritic complexity and function of NAc MSNs.
Blunted MSN morphology may be responsible for the increase in anxiety-like behaviors seen in
mice. Further analysis of this data may guide future efforts to construct the implications of
RPRD2 on Anxiety Disorders and uncover novel molecular pathways to target for treatment
efforts.
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